Detailed Canine Results Qualified Broad Cannabis Respiratory and Blood-Pressure Nulls
Although the canine cannabis paper broadly described respiratory function and blood pressure as largely unaffected, its detailed results included isolated significant comparisons. A summary of mostly null findings should preserve those exceptions.
The respiratory measures did not all agree
Respiratory rate and tidal volume did not show significant changes under the reported conditions. The results nevertheless describe reduced minute volume with THC at one cumulative dose compared with baseline. The absence of a significant respiratory-rate change is therefore not equivalent to a null result for every breathing measure.
Blood pressure had a specific exception as well
The paper reports increased mean blood pressure with the THC–CBD combination at the highest cumulative dose relative to baseline. Other pressure changes were described largely as nonsignificant trends. These findings should not be collapsed either into no pressure effect anywhere or into a uniform hypertensive response.
The evidence is acute and exploratory
Six male Beagles underwent several measurements across escalating exposures. Isolated significant findings warrant precise reporting, while their reproducibility and clinical importance need separate evidence. The trial does not establish a human respiratory-risk threshold, and statistical nonsignificance elsewhere does not demonstrate exact equivalence. The defensible account is that most respiratory and pressure measures were unchanged, with named exceptions in the detailed results. This preserves the main pattern without allowing a broad abstract statement to erase narrower observations in the body of the paper.
Related analysis: the canine study’s separate physiological outcomes.
Research cited
Rutjanavate, Dong and Sawangkoon. Cumulative Effects of Cannabis Oils on Body Temperature, Electrocardiography, Heart Rate Variability, Blood Pressure, and Respiratory Function in Telemetered Dogs. DOI: 10.4103/IJVSM.IJVSM_3_25.
